Foresee Pharmaceuticals Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 60.72 million compared to TWD 18.11 million a year ago. Net loss was TWD 236.56 million compared to TWD 164.09 million a year ago. Basic loss per share from continuing operations was TWD 1.74 compared to TWD 1.39 a year ago. Diluted loss per share from continuing operations was TWD 1.74 compared to TWD 1.39 a year ago.
For the nine months, sales was TWD 126.62 million compared to TWD 291.75 million a year ago. Net loss was TWD 697.74 million compared to TWD 264.59 million a year ago. Basic loss per share from continuing operations was TWD 5.61 compared to TWD 2.24 a year ago. Diluted loss per share from continuing operations was TWD 5.61 compared to TWD 2.24 a year ago.